According to Prevention Magazine's 13th annual national survey Consumer Reaction to DTC Advertising of Prescription Drugs, the majority of respondents believe TV and magazine DTC ads are adhering to the FDA's "fair balance" regulation (this mandate requires that pharma DTC ads present a fair balance of risk and benefit information). But, while consumers are now accustomed to hearing risk information and its recognizable format on TV ads, there responses indicate that there is much room for improving online DTC ads in this area. Other survey questions provided insights around use of social media for health information and type of information consumers sought to obtain.
To find out more about the survey results, click here.
Friday, July 16, 2010
Friday, July 2, 2010
DDMAC Warning / Untitled Letters - Impact on Pharma
As many of us know, the FDA's DDMAC has been increasing its staff and stepping up its issuance of warning and untitled letters (also called notice of violation letters) for violative promotional activities. In fact, according the FDA's website warning and untitled letters have risen from 21 in 2008 to 41 in 2009. Mid-way through 2010, we have already seen the number hit 38.
As the number of these letters continue to rise, I wonder how this is impacting the perspectives of promotional material reviewers. Is the first thought around communicating messages with the patient in mind or regulators? The reality is that regulatory compliance is a part of our everyday lives. But I hope that marketers and reviewers continue to place the safety and concerns of patients first.
As the number of these letters continue to rise, I wonder how this is impacting the perspectives of promotional material reviewers. Is the first thought around communicating messages with the patient in mind or regulators? The reality is that regulatory compliance is a part of our everyday lives. But I hope that marketers and reviewers continue to place the safety and concerns of patients first.
Subscribe to:
Posts (Atom)
Posts
